Tag: diagnostics industry

January 23, 2018

ChroMedX Appoints Dr. Richard Janeczko as Chief Commercial Officer; Jessica Kuhn as Chief Operations Officer

ChroMedX Corp. (CSE: CHX) (OTCQB: CHXIF) (FSE: EIY2) (the "Company"), developer of the HemoPalm Handheld Blood Analyzer System, is pleased...
January 3, 2018

ChroMedX Corp. Executes Definitive Agreement with DxEconomix to Lead Value-Based Transactions

ChroMedX Corp. (CSE:CHX) (OTC:CHXIF) (FSE: EIY2), (the “Company”), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to report...
December 19, 2017

Co-Diagnostics Enters Into Lease for New Laboratory Facility

Co-Diagnostics announced the leasing of a new CGMP-ready and Biological Safety Level 2 laboratory facility in Salt Lake City.
December 13, 2017

ChroMedX Announces Exercise of Warrants

ChroMedX Corp. (CSE:CHX) (OTC: CHXIF) (FSE: EIY2) (the “Company”), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to...
December 7, 2017

ChroMedX Strengthens Board of Directors with the Appointment of Dr. Richard Janeczko

ChroMedX Corp. (CSE:CHX) (OTCQB: CHXIF) (FSE: EIY2) (the “Company”), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to...
November 27, 2017

ChroMedX Accepts Proposal; Signs LOI with Diagnostic Marketing Experts to Conduct a Value-Based Transaction for the HemoPalm Blood Analyzer System

ChroMedX Corp. (CSE:CHX) (OTCQB: CHXIF) (FSE: EIY2) (the “Company“), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to...
November 24, 2017

ChroMedX Agrees Have DxEconmix Promote HemoPalm

ChroMedX Corp. (CSE:CHX) (OTCQB: CHXIF) (FSE: EIY2) (the “Company“), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to...